 |
cancer. Science 1994, 266:2011-2015.
3. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO,
Reddel RR: The hTERTα splice variant is a dominant negative
inhibitor of telomerase activity. Neoplasia 2000, 2:426-432.
4. Ulaner GA, Hu JF, Vu TH, Giudice LC, Hoffman AR: Tissue-specific
alternate sp
|
|
메뉴펼치기
